Tracerx | search
Click here to view Tracerx news from 60+ newspapers.
Bookmark or Share- TRACERx EVO, a new programme to transform lung cancer researchThe newly established TRACERx EVO consortium involves international experts from across Europe and North America – combining world-leading scientific and clinical expertise to build on the wide-reaching foundations laid by TRACERx. The ambitious programme will pursue multiple avenues of research.
- The evolution of non-small cell lung cancer metastases in TRACERxWe present the results of TRACERx, a longitudinal study tracking the evolution of early-stage NSCLC through space and time, representative of real-world experience within a universal healthcare...
- TRACERx - NatureTRACERx. Cancers evolve at a dynamic pace to adapt to immune pressure, colonize new niches, and evade therapy. Tracking these changes can help us improve diagnosis, better tailor therapies, and...
- The evolution of lung cancer and impact of subclonal selection in TRACERxHere we analysed 1,644 tumour regions sampled at surgery or during follow-up from the first 421 patients with non-small cell lung cancer prospectively enrolled into the TRACERx study.
- Tracking the Evolution of Non–Small-Cell Lung Cancer | NEJMTracking Non–Small-Cell Lung Cancer Evolution through Therapy (TRACERx) 10 is a multicenter, prospective cohort study, which began recruitment in April 2014 with funding from Cancer...
More
